Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NYU Langone Health
Lymphocytic infiltrates were seen in never-injected nodules only after several weeks of injections elsewhere. No adverse events were seen. The tumor-infiltrating lymphocytes were able to kill autologous melanoma ex vivo. Some patients who experienced complete regressions of all metastases lived without disease for over 10 years.
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Multiple cutaneous or subcutaneous metastases of melanoma
You may not be if
Visceral metastases on admission.
No current chemotherapy or immunotherapy.
Note study performed between 1978 and 2002 before current therapies were available.
Clareo Health | Inducing Systemic Immunity and Regressions in Metastatic Melanoma
